These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25708651)

  • 21. Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.
    Mellon SH; Wolkowitz OM; Schonemann MD; Epel ES; Rosser R; Burke HB; Mahan L; Reus VI; Stamatiou D; Liew CC; Cole SW
    Transl Psychiatry; 2016 May; 6(5):e821. PubMed ID: 27219347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial treatment approaches for patients with major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009 Jun; 70(6):e18. PubMed ID: 19573474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change.
    Lopresti AL; Maes M; Meddens MJ; Maker GL; Arnoldussen E; Drummond PD
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):38-50. PubMed ID: 25523883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mRNA Expression of
    Rhein C; Zoicas I; Marx LM; Zeitler S; Hepp T; von Zimmermann C; Mühle C; Richter-Schmidinger T; Lenz B; Erim Y; Reichel M; Gulbins E; Kornhuber J
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response.
    Hennings JM; Uhr M; Klengel T; Weber P; Pütz B; Touma C; Czamara D; Ising M; Holsboer F; Lucae S
    Transl Psychiatry; 2015 Mar; 5(3):e538. PubMed ID: 25826113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major depression and its treatment: microRNAs as peripheral biomarkers of diagnosis and treatment response.
    Lopez JP; Kos A; Turecki G
    Curr Opin Psychiatry; 2018 Jan; 31(1):7-16. PubMed ID: 29076893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Criticisms of drugs in early development for the treatment of depression: what can be improved?
    Wang SM; Han C; Pae CU
    Expert Opin Investig Drugs; 2015 Apr; 24(4):445-53. PubMed ID: 25529224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of IL-2 and soluble IL-2R in depression and antidepressant response.
    Eller T; Vasar V; Shlik J; Maron E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):638-43. PubMed ID: 19579169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide association studies of antidepressant outcome: a brief review.
    Laje G; McMahon FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1553-7. PubMed ID: 21115088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(1):145-8. PubMed ID: 17196755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity.
    Carrillo-Roa T; Labermaier C; Weber P; Herzog DP; Lareau C; Santarelli S; Wagner KV; Rex-Haffner M; Harbich D; Scharf SH; Nemeroff CB; Dunlop BW; Craighead WE; Mayberg HS; Schmidt MV; Uhr M; Holsboer F; Sillaber I; Binder EB; Müller MB
    PLoS Biol; 2017 Dec; 15(12):e2002690. PubMed ID: 29283992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
    Trivedi MH; Lin EH; Katon WJ
    CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
    Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
    Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evening salivary alpha-amylase, major depressive disorder, and antidepressant use in the Netherlands Study of Depression and Anxiety (NESDA).
    Veen G; Giltay EJ; Licht CM; Vreeburg SA; Cobbaert CM; Penninx BW; Zitman FG
    Psychiatry Res; 2013 Jun; 208(1):41-6. PubMed ID: 23587658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers predicting antidepressant treatment response: how can we advance the field?
    Labermaier C; Masana M; Müller MB
    Dis Markers; 2013; 35(1):23-31. PubMed ID: 24167346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can people with nonsevere major depression benefit from antidepressant medication?
    Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
    J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder.
    Yi Z; Li Z; Yu S; Yuan C; Hong W; Wang Z; Cui J; Shi T; Fang Y
    PLoS One; 2012; 7(2):e31283. PubMed ID: 22348066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of antidepressant action: an integrated dopaminergic perspective.
    Porcelli S; Drago A; Fabbri C; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1532-43. PubMed ID: 21402119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.